WeVote
Log In

Bill

Bill

S 3932

Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

2024-2025 Regular Session Introduced by Raj Mukherji and 1 co-sponsor

New Jersey Transit must pilot naloxone distribution on light rail trains with $100,000 funding to address opioid overdoses during transit emergencies.

Referred to Senate Budget and Appropriations Committee
#freightrail
0
WeVote Research Nonpartisan
Bill Summary · S 3932

Legislative bill overview

S 3932 requires New Jersey Transit (NJT) to establish a pilot program that equips certain light rail train sets with opioid antidotes (naloxone/Narcan) and provides staff training on their use. The bill appropriates $100,000 to fund this initiative.

Why is this important

Opioid overdoses remain a public health crisis, and transit systems serve vulnerable populations with high overdose risk. Having naloxone readily available on trains could enable rapid intervention and save lives during overdose emergencies in enclosed spaces where emergency response time matters significantly.

Potential points of contention

  • Cost-effectiveness and scalability: $100,000 for a pilot may be insufficient for comprehensive implementation across NJT's light rail system, raising questions about whether this is a meaningful intervention or primarily symbolic
  • Liability and training concerns: Unclear provisions around staff liability if naloxone administration goes wrong, staff willingness to intervene, and whether transit workers should bear this responsibility beyond their primary duties
  • Coverage gaps: Light rail represents only one transit mode; critics may argue resources should address overdose prevention more broadly (buses, stations, platforms) or focus on upstream prevention rather than emergency response

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.